A pharmacodynamic study of the optimal P2Y12 inhibitor regimen for East Asian patients with acute coronary syndrome
Ji Hyun Lee, Sung Gyun Ahn, Bonil Park, Sang Wook Park, Yong Seok Kang, Jun-Won Lee, Young Jin Youn, Min-Soo Ahn, Jang-Young Kim, Byung-Su Yoo, Seung-Hwan Lee, Junghan Yoon
Korean J Intern Med. 2015;30(5):620-628.   Published online 2015 Aug 27     DOI: https://doi.org/10.3904/kjim.2015.30.5.620
Citations to this article as recorded by Crossref logo
One-Month Dual Antiplatelet Therapy in High Bleeding Risk Asian Patients Undergoing Percutaneous Coronary Intervention ― Onyx ONE Clear 2-Year Results ―
Jeehoon Kang, Abdul Kahar Abdul Ghapar, Kamaraj Selvaraj, Seung-Ho Hur, Chor Cheung Tam, Yangsoo Jang, In-Ho Chae, David E. Kandzari, Ajay J. Kirtane, Azeem Latib, Elvin Kedhi, Te-Hsin Lung, So-Jeong You, Stephan Windecker, Gregg W. Stone, Hyo-Soo Kim
Circulation Reports.2024; 6(8): 333.     CrossRef
Effect of Cangrelor on Infarct Size in ST-Segment–Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (The PITRI Trial)
Heerajnarain Bulluck, Jun Hua Chong, Jennifer Bryant, Annitha Annathurai, Ping Chai, Mervyn Chan, Ashish Chawla, Chee Yang Chin, Yiu-Cho Chung, Fei Gao, Hee Hwa Ho, Andrew Fu Wah Ho, John Hoe, Syed Saqib Imran, Chi-Hang Lee, Benji Lim, Soo Teik Lim, Swee
Circulation.2024; 150(2): 91.     CrossRef
Prasugrel dose de-escalation in diabetic patients with acute coronary syndrome receiving percutaneous coronary intervention: results from the HOST-REDUCE-POLYTECH-ACS trial
Kyu-Sun Lee, Keun-Ho Park, Kyung Woo Park, Seung-Woon Rha, Doyeon Hwang, Jeehoon Kang, Jung-Kyu Han, Han-Mo Yang, Hyun-Jae Kang, Bon-Kwon Koo, Nam-ho Lee, Jay Young Rhew, Kook Jin Chun, Young-Hyo Lim, Jung Min Bong, Jang-Whan Bae, Bong Ki Lee, Seok-Yeon K
European Heart Journal - Cardiovascular Pharmacotherapy.2023;[Epub]     CrossRef
Trade-off of major bleeding versus myocardial infarction on mortality after percutaneous coronary intervention
Andrew Kei-Yan Ng, Pauline Yeung Ng, April Ip, Lap Tin Lam, Chung-Wah Siu
Open Heart.2022; 9(1): e001861.     CrossRef
The Effect of Ticagrelor on Endothelial Function Compared to Prasugrel, Clopidogrel, and Placebo: A Systematic Review and Meta-Analysis
Baoyi Guan, Lin Zhao, Dan Ma, Yixuan Fan, He Zhang, Anlu Wang, Hao Xu
Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
Risk of ischaemic and haemorrhagic stroke in Chinese undergoing percutaneous coronary intervention treated with potent P2Y12 inhibitor versus clopidogrel
Andrew Kei-Yan Ng, Pauline Yeung Ng, April Ip, Kui Kai Lau, Chung-Wah Siu
Stroke and Vascular Neurology.2022; 7(4): 310.     CrossRef
Differences in Optimal Platelet Reactivity after Potent P2Y12 Inhibitor Treatment in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
Kai Song, Xuan Jin, Moo-Hyun Kim, Jia-Xin Li, Cai-De Jin, Song-Lin Yuan, Zhao-Yan Song, En-Ze Jin, Kwang-Min Lee, Kyung-Hee Lim, Young-Rak Cho
Journal of Clinical Medicine.2022; 11(9): 2480.     CrossRef
Incidence, Prediction, and Outcomes of Major Bleeding After Percutaneous Coronary Intervention in Chinese Patients
Andrew Kei-Yan Ng, Pauline Yeung Ng, April Ip, Ian Wood-Hay Ling, Lap-Tin Lam, Chung-Wah Siu
JACC: Asia.2022; 2(3): 341.     CrossRef
Impact of Prasugrel and Ticagrelor on Platelet Reactivity in Patients With Acute Coronary Syndrome: A Meta-Analysis
Lulu Dai, Jiawei Xu, Yuerong Jiang, Keji Chen
Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
Antiplatelet Therapy Aims and Strategies in Asian Patients with Acute Coronary Syndrome or Stable Coronary Artery Disease
Chor-Cheung Tam, Hung-Fat Tse
Journal of Clinical Medicine.2022; 11(24): 7440.     CrossRef
The effect of antiplatelet drug on coronary endothelial and microvascular function: comparison with ticagrelor and clopidogrel
Woong Gil Choi, Gi Chang Kim, Cheol Ho Lee, Hye Young Kim, Dong Woon Kim
The Korean Journal of Internal Medicine.2021; 36(2): 352.     CrossRef
Pharmacodynamics and Outcomes of a De-Escalation Strategy with Half-Dose Prasugrel or Ticagrelor in East Asians Patients with Acute Coronary Syndrome: Results from HOPE-TAILOR Trial
Cai-De Jin, Moo-Hyun Kim, Kai Song, Xuan Jin, Kwang-Min Lee, Jong-Sung Park, Young-Rak Cho, Sung-Cheol Yun, Michael S. Lee
Journal of Clinical Medicine.2021; 10(12): 2699.     CrossRef
Increased platelet inhibition after switching from prasugrel to low-dose ticagrelor in Japanese patients with prior myocardial infarction
Kazuya Tateishi, Yuichi Saito, Hideki Kitahara, Takashi Nakayama, Yoshihide Fujimoto, Yoshio Kobayashi
Journal of Cardiology.2020; 75(5): 473.     CrossRef
Platelet activity with hemoglobin level in patients with hemodialysis
Jae Min Kim, Jin Sug Kim, Hyung Oh Kim, So Ra Lee, Jae Hwan Rhew, Jong Shin Woo, Jang Hyun Cho, Kyung Hwan Jeong, Weon Kim
Medicine.2020; 99(10): e19336.     CrossRef
Platelet inhibition to target reperfusion injury trial: Rationale and study design
Heerajnarain Bulluck, Mervyn H. H. Chan, Jennifer A. Bryant, Ping Chai, Ashish Chawla, Terrance S. Chua, Yiu‐Cho Chung, Gao Fei, Hee H. Ho, Andrew F. W. Ho, Andrew J. Hoe, Syed S. Imran, Chi‐Hang Lee, Swee H. Lim, Boon W. Liew, Patrick L. Z. Yun, Marcus O
Clinical Cardiology.2019; 42(1): 5.     CrossRef
2018 update of expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI
Yong Huo, Young-Hoon Jeong, Yanjun Gong, Daowen Wang, Ben He, Jiyan Chen, Guosheng Fu, Yundai Chen, Jianping Li, Yi Li, Shinya Goto, Udaya S. Tantry, Paul A. Gurbel, Jong-Hwa Ahn, Hyo-Soo Kim, Myung Ho Jeong, Yaling Han, Sidney C. Smith, Junbo Ge
Science Bulletin.2019; 64(3): 166.     CrossRef
Comparison of 1-year clinical outcomes between prasugrel and ticagrelor versus clopidogrel in type 2 diabetes patients with acute myocardial infarction underwent successful percutaneous coronary intervention
Kye Taek Ahn, Seok-Woo Seong, Ung Lim Choi, Seon-Ah Jin, Jun Hyung Kim, Jae-Hwan Lee, Si Wan Choi, Myung Ho Jeong, Shung Chull Chae, Young Jo Kim, Chong Jin Kim, Hyo-Soo Kim, Myeong-Chan Cho, Hyeon-Cheol Gwon, Jin-Ok Jeong, In-Whan Seong
Medicine.2019; 98(11): e14833.     CrossRef
Author's reply
Keun-Ho Park, Myung Ho Jeong
Journal of Cardiology.2018; 71(2): 213.     CrossRef
Higher Risk of Bleeding in Asians Presenting With ST Elevation Myocardial Infarction (STEMI)
Ana Karolina Víquez Beita, Thomas F. Whayne
Angiology.2018; 69(6): 461.     CrossRef
The pharmacodynamics of low and standard doses of ticagrelor in patients with end stage renal disease on hemodialysis
Jin Sug Kim, Jong Shin Woo, Jin Bae Kim, Woo-Shik Kim, Tae Won Lee, Kwon Sam Kim, Chun Gyoo Ihm, Weon Kim, Kyung Hwan Jeong
International Journal of Cardiology.2017; 238: 110.     CrossRef
East Asian perspective on the interaction between proton pump inhibitors and clopidogrel
Duowu Zou, Khean‐Lee Goh
Journal of Gastroenterology and Hepatology.2017; 32(6): 1152.     CrossRef
Switching from prasugrel to clopidogrel based on Cytochrome P450 2C19 genotyping in East Asian patients stabilized after acute myocardial infarction
Ji Hyun Lee, Sung Gyun Ahn, Jun-Won Lee, Young Jin Youn, Min-Soo Ahn, Jang-Young Kim, Byung-Su Yoo, Seung-Hwan Lee, Junghan Yoon, Juwon Kim, Eunhee Choi, Sang-Yong Yoo, Olivia Y. Hung, Habib Samady
Platelets.2016; 27(4): 301.     CrossRef